Impact of COVID‐19 in patients with autoimmune bullous diseases: Report from an international registry.

Autor:	Meijer, Joost M., Rashid, Hanan, Vergadi, Styliani, Antiga, Emiliano, Vezzoli, Pamela, Balestri, Riccardo, Patsatsi, Aikaterini, Uzun, Soner, Skiljevic, Dusan, Jedlickova, Hana, Janickova, Lucia, Corrà, Alberto, Ponziani, Alessandra, Günther, Claudia, Cianchini, Giuseppe, Schefzyk, Matthias, Marzano, Angelo, Di Zenzo, Giovanni, Shimanovich, Iakov, Fairley, Janet
Předmět:	BULLOUS pemphigoid REPORTING of diseases COVID-19 AUTOIMMUNE diseases MEDICAL personnel COVID-19 pandemic
Zdroj:	Journal of the European Academy of Dermatology & Venereology; Oct2023, Vol. 37 Issue 10, pe1189-e1191, 3p
Abstrakt:	In summary, this international registry showed a rather stable disease activity in the majority of AIBD patients following COVID-19 infection. Death occurred in nine patients (13%) with a mean age of 84.3 years; 6 of the 9 patients (67%) of them died during hospitalization for COVID-19 infection. Respectively, the change in disease activity of AIBD before and after COVID-19 infection is shown in Figure 1d. 1 TABLE Reported systemic treatment for AIBD before and after COVID-19 infection. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text